Radiolabeling and In-Silico Study of 131I-(4-fluorobenzoyl-3-methylthiourea) as Radiopharmaceuticals for Breast Cancer Theranostics. Valensi [Internet]. 2024 May 31 [cited 2025 Oct. 27];10(1):27-44. Available from: https://journal.uinjkt.ac.id/valensi/article/view/34258